Zhejiang Garden Biopharmaceutical Co.,Ltd. (SZSE: 300401)
Health Care · Pharmaceuticals · CN
CN¥15.44
-3.08% today · -2.8% 1Y
Zhejiang Garden Biopharmaceutical Co.,Ltd. (SZSE: 300401) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.25B and employs 1,163 people.
Over the last twelve months the share price has lost 2.8%, trading between 10.68 and 23.44.
Tweenvest scores Zhejiang Garden Biopharmaceutical Co.,Ltd. across four factors: quality 68/100, value 41/100, growth 38/100, dividend 17/100. Its strongest factor is quality.
300401 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.25B
- Revenue (TTM)
- $190.52M
- P/E
- 33.44
- EPS
- 0.46
- Dividend yield
- 0.73%
- Beta (5Y)
- 0.44
- 52-week high
- CN¥23.44
- 52-week low
- CN¥10.68
- Avg volume (3M)
- —
- Shares outstanding
- 543.69M
- Employees
- 1,163
- Next earnings
- —
About Zhejiang Garden Biopharmaceutical Co.,Ltd.
Zhejiang Garden Biopharmaceutical Co.,Ltd. operates as a food additive and pharmaceutical manufacturing industry in China. The company provides lanolin cholesterol, vitamin A and AD3 particles, vitamin D3, 25-hydroxyvitamin D3, chemical drugs and Chinese patent medicines. It offers cholesterol; feed grade vitamin D3, refined lanolin; food additives compound nutrient fortifier SDS, CO, and MO; cholecalciferol; feed additive - vitamin D3 particles and oil; VD3 resin oil; 25 hydroxyvitamin D3 progen and powder; 25 hydroxyvitamin D3; anhydrous lanolin; wood oil; wool wax; low chroma pure fat; lanolin alcohol; isopropyl lanolate; lanolinic acid; high acid fat; wood acid biofuel/wood alcohol biofuel; and rodenticide made from Vitamin D3. Zhejiang Garden Biopharmaceutical Co.,Ltd. was formerly known as Zhejiang Garden Bio-chemical High-tech Co., Ltd. and changed its name to Zhejiang Garden Biopharmaceutical Co.,Ltd. in April 2023. Zhejiang Garden Biopharmaceutical Co.,Ltd. was founded in 2000 and is based in Dongyang, China.
- ISIN
- CNE100001XX7
- Founded
- 2000
- Listed since
- Oct 9, 2014
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,239.69 | -1.25% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.54 | +0.48% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $149.86 | -1.76% |
| Roche Holding AGSWX: ROP | $373.91B | CHF369.10 | -1.73% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £120.32 | -1.70% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.88 | -0.68% |
Figures last refreshed Aug 18, 2026.